Register entryShortage reported
Teyro Labs Private Limited
- Registered sites
- 1
- Drug products
- 8
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Teyro Labs Private Limited | Kanchipuram DistrictIndia | Analytical testing, Finished drug manufacture, Packaging | 3021389808 |
Alert
Products in shortage
4| Drug | Presentation | Availability |
|---|---|---|
| Carboplatin Injection | Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1) | Unavailable |
| Carboplatin Injection | Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3) | Unavailable |
| Carboplatin Injection | Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6) | Unavailable |
| Carboplatin Injection | Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7) | Unavailable |
Catalogue
Marketed products
8Showing 8 of 8.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| CARBOPLATIN | CARBOPLATIN | INJECTION, SOLUTION | ANDA |
| CARBOPLATIN | CARBOPLATIN | INJECTION, SOLUTION | ANDA |
| CARBOPLATIN | CARBOPLATIN | INJECTION, SOLUTION | ANDA |
| CARBOPLATIN | CARBOPLATIN | INJECTION, SOLUTION | ANDA |
| Capecitabine | capecitabine | TABLET, FILM COATED | ANDA |
| Capecitabine | capecitabine | TABLET, FILM COATED | ANDA |
| Gemcitabine hydrochloride | Gemcitabine hydrochloride | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | ANDA |
| Gemcitabine hydrochloride | Gemcitabine hydrochloride | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | ANDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.